Keywords: MR-Guided Interventions, Prostate, Cancer
Motivation: Prostate cancer is a leading cause of cancer in men, with limited minimally invasive focal treatments available. This study explores MRI-guided cryoablation as a precise alternative to traditional therapies.
Goal(s): To evaluate the efficacy and safety of MRI-guided trans-perineal cryoablation in reducing PSA levels and recurrence rates while managing adverse effects in prostate cancer patients.
Approach: In a prospective study, 100 patients received MRI-guided cryoablation with four cryoneedles and freeze/thaw cycles, followed by PSA, MRI, and biopsy monitoring.
Results: One-year follow-up showed up to 60% PSA reduction, an 11.1% recurrence rate, and manageable urinary and erectile side effects.
Impact: MRI-guided trans-perineal cryoablation shows promise as a minimally invasive, precise treatment for localized prostate cancer, with significant PSA reductions and a low 11.1% recurrence rate. These findings support its potential as an effective alternative to traditional therapies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords